{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "443",
                "494"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca - ubytek przedsionkowo-komorowy"
        },
        {
            "identifier": "T2",
            "position": [
                "497",
                "535"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "ubytek mi\u0119dzyprzedsionkowy typu ASD II"
        },
        {
            "identifier": "T3",
            "position": [
                "540",
                "561"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Niewydolno\u015b\u0107 kr\u0105\u017cenia"
        },
        {
            "identifier": "T4",
            "position": [
                "566",
                "577"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Trisomia 21"
        },
        {
            "identifier": "T5",
            "position": [
                "698",
                "707"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "identifier": "T6",
            "position": [
                "709",
                "717"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironol"
        },
        {
            "identifier": "T7",
            "position": [
                "719",
                "728"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Captopril"
        },
        {
            "identifier": "T8",
            "position": [
                "730",
                "739"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Diflos 30"
        },
        {
            "identifier": "T10",
            "position": [
                "741",
                "750"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Esputicon"
        },
        {
            "identifier": "T11",
            "position": [
                "752",
                "762"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "5% glukoza"
        },
        {
            "identifier": "T12",
            "position": [
                "902",
                "921"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {
            "identifier": "T13",
            "position": [
                "924",
                "938"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "zespo\u0142em Downa"
        },
        {},
        {
            "icd": "ICD10:Q21.2",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody przedsionkowo-komorowej"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N2",
            "referenced": "T2",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        },
        {
            "icd": "ICD10:I50",
            "identifier": "N3",
            "referenced": "T3",
            "subtype": "Reference",
            "type": "N",
            "value": "Niewydolno\u00c5\u009b\u00c4\u0087 serca"
        },
        {
            "icd": "ICD10:Q90",
            "identifier": "N4",
            "referenced": "T4",
            "subtype": "Reference",
            "type": "N",
            "value": "Zesp\u00c3\u00b3\u00c5\u0082 Downa"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N5",
            "referenced": "T12",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "icd": "ICD10:Q90",
            "identifier": "N6",
            "referenced": "T13",
            "subtype": "Reference",
            "type": "N",
            "value": "Zesp\u00c3\u00b3\u00c5\u0082 Downa"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 3 miesi\u0119cy\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca - ubytek przedsionkowo-komorowy + ubytek mi\u0119dzyprzedsionkowy typu ASD II.\\x0aNiewydolno\u015b\u0107 kr\u0105\u017cenia.\\x0aTrisomia 21.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolin, Spironol, Captopril, Diflos 30, Esputicon, 5% glukoza.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca i zespo\u0142em Downa przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nPotas: K:5.40[mmol/L]\nPotas: K:5.20[mmol/L]\nPotas: K:4.90[mmol/L]\nPotas: K:4.50[mmol/L]\nPotas: K:5.80[mmol/L]\nS\u00f3d: Na:136.00[mmol/L]\nS\u00f3d: Na:138.00[mmol/L]\nS\u00f3d: Na:136.00[mmol/L]\nS\u00f3d: Na:138.00[mmol/L]\nS\u00f3d: Na:138.00[mmol/L]\nRKZ Parametry krytyczne\n    pH:7.341\n    pCO2:51.0[mmHg]\n    BE:0.90[mmol/L]\n    HCO3:26.8[mmol/L]\n    pO2:33.9[mmHg]\n    O2Sat:59.9[%]\n    COMMENT_HL7:\nRKZ Parametry krytyczne\n    pH:7.343\n    pCO2:47.2[mmHg]\n    BE:-0.60[mmol/L]\n    HCO3:25.0[mmol/L]\n    pO2:53.7[mmHg]\n    O2Sat:84.1[%]\n    COMMENT_HL7:\nRKZ Parametry krytyczne\n    pH:7.376\n    pCO2:43.9[mmHg]\n    BE:0.30[mmol/L]\n    HCO3:25.2[mmol/L]\n    pO2:42.0[mmHg]\n    O2Sat:73.3[%]\n    COMMENT_HL7:\nRKZ Parametry krytyczne\n    pH:7.316\n    pCO2:49.7[mmHg]\n    BE:-1.40[mmol/L]\n    HCO3:24.6[mmol/L]\n    pO2:36.8[mmHg]\n    O2Sat:62.1[%]\n    COMMENT_HL7:\nMorfologia\n    WBC:6.85[10\\\\^3/ul]\n    RBC:4.55[10\\\\^6/ul]\n    HGB:12.2[g/dl]\n    HCT:38.2[%]\n    MCV:84.0[fl]\n    MCH:26.8[pg]\n    MCHC:31.9[g/dl]\n    PLT:398.0[10\\\\^3/ul]\n    RDW-SD:42.5[fl]\n    RDW-CV:13.9[%]\n    PDW:11.4[fl]\n    MPV:10.3[fl]\n    P-LCR:26.8[%]\n    PCT:0.4[%]\n    NEUTR#:2.64[10\\\\^3/ul]\n    NEUTR%:38.5[%]\n    LYMPH#:3.48[10\\\\^3/ul]\n    LYMPH%:50.8[%]\n    MONO#:0.47[10\\\\^3/ul]\n    MONO%:6.90[%]\n    EO#:0.19[10\\\\^3/ul]\n    EO%:2.80[%]\n    BASO#:0.07[10\\\\^3/ul]\n    BASO%:1.00[%]\n    NRBC %:0.10[%]\n    NRBC#:0.01[10\\\\^3/ul]\nMorfologia\n    WBC:5.04[10\\\\^3/ul]\n    RBC:4.42[10\\\\^6/ul]\n    HGB:12.3[g/dl]\n    HCT:36.2[%]\n    MCV:81.9[fl]\n    MCH:27.8[pg]\n    MCHC:34.0[g/dl]\n    PLT:356.0[10\\\\^3/ul]\n    RDW-SD:41.4[fl]\n    RDW-CV:14.1[%]\n    PDW:11.8[fl]\n    MPV:10.8[fl]\n    P-LCR:29.5[%]\n    PCT:0.4[%]\n    NEUTR#:2.14[10\\\\^3/ul]\n    NEUTR%:42.4[%]\n    LYMPH#:1.94[10\\\\^3/ul]\n    LYMPH%:38.5[%]\n    MONO#:0.82[10\\\\^3/ul]\n    MONO%:16.30[%]\n    EO#:0.07[10\\\\^3/ul]\n    EO%:1.40[%]\n    BASO#:0.07[10\\\\^3/ul]\n    BASO%:1.40[%]\n    NRBC %:0.20[%]\n    NRBC#:0.01[10\\\\^3/ul]\nMorfologia\n    WBC:7.18[10\\\\^3/ul]\n    RBC:4.52[10\\\\^6/ul]\n    HGB:12.3[g/dl]\n    HCT:37.1[%]\n    MCV:82.1[fl]\n    MCH:27.2[pg]\n    MCHC:33.2[g/dl]\n    PLT:386.0[10\\\\^3/ul]\n    RDW-SD:41.1[fl]\n    RDW-CV:14.2[%]\n    PDW:11.5[fl]\n    MPV:10.8[fl]\n    P-LCR:29.2[%]\n    PCT:0.4[%]\n    NEUTR#:2.19[10\\\\^3/ul]\n    NEUTR%:30.5[%]\n    LYMPH#:4.45[10\\\\^3/ul]\n    LYMPH%:62.0[%]\n    MONO#:0.44[10\\\\^3/ul]\n    MONO%:6.10[%]\n    EO#:0.09[10\\\\^3/ul]\n    EO%:1.30[%]\n    BASO#:0.01[10\\\\^3/ul]\n    BASO%:0.10[%]\n    NRBC %:0.10[%]\n    NRBC#:0.01[10\\\\^3/ul]\nABL Parametry krytyczne\n    pH:7.183\n    pCO2:56.7[mmHg]\n    BE:-8.10[mmol/L]\n    HCO3:20.5[mmol/L]\n    pO2:47.1[mmHg]\n    O2Sat:69.6[%]\n    Na - ABL:137[mmol/L]\n    K - ABL:6.0[mmol/L]\n    Cl - ABL:105[mmol/L]\n    Ca zj ABL:1.41[mmol/L]\n    Ht - ABL:41.6[%]\n    Hb ABL:13.5[g/dl]\n    FO2Hb:68.5[%]\n    FCOHb:1.0[%]\n    FMetHb:0.6[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:181[mg/dl]\n    mleczany:75[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.292\n    pCO2:43.9[mmHg]\n    BE:-5.30[mmol/L]\n    HCO3:20.5[mmol/L]\n    pO2:35.8[mmHg]\n    O2Sat:61.4[%]\n    Na - ABL:114[mmol/L]\n    K - ABL:7.3[mmol/L]\n    Cl - ABL:89[mmol/L]\n    Ca zj ABL:1.12[mmol/L]\n    Ht - ABL:33.9[%]\n    Hb ABL:11.0[g/dl]\n    FO2Hb:60.5[%]\n    FCOHb:0.9[%]\n    FMetHb:0.6[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:86[mg/dl]\n    mleczany:36[mg/dl]\n    COMMENT_HL7:\nBadanie og\u00f3lne moczu\n    Barwa:\u017c\u00f3\u0142ta\n    Przej:zupe\u0142na\n    SG:1.005\n    pH:6.0\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cony\n    BIL:nieobecna\n    ERY:nieobecne[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nBadania immunoenzymatyczne: COMMENT_HL7:\nImmunochemia - serologia chor\u00f3b zaka\u017anych: COMMENT_HL7:\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nR\u00f3\u017cyczka IgM: RUBM:Ujemny(0.08)\nR\u00f3\u017cyczka IgG: RUBG:Dodatni(34)[IU/ml]\nFibrynogen (F): FIB:1.91[g/L]\nFibrynogen (F): FIB:1.77[g/L]\nAntytrombina III (ATIII): ATIII:94.0[%]\nAntytrombina III (ATIII): ATIII:87.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:26.6[s]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:25.8[s]\nINR: INR:1.0\nINR: INR:1.0\nCzas protrombinowy (PT): PT:11.3[s]\nCzas protrombinowy (PT): PT:11.4[s]\nCzas trombinowy (TT): TT:18.9[s]\nCzas trombinowy (TT): TT:18.2[s]\nChlorki: Cl:101.00[mmol/L]\nChlorki: Cl:102.00[mmol/L]\nChlorki: Cl:100.00[mmol/L]\nChlorki: Cl:102.00[mmol/L]\nAdenowirusy: ADENO-KA\u0141:ujemny\nWap\u0144 ca\u0142kowity: Ca:2.53[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.63[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.52[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.53[mmol/L]\nWap\u0144 ca\u0142kowity: Ca:2.70[mmol/L]\nMagnez: Mg:0.92[mmol/L]\nMagnez: Mg:0.89[mmol/L]\nMagnez: Mg:0.88[mmol/L]\nGGTP gammaglutamylotranspeptydaza: GGT:19.00[IU/L]\nFosfataza alkaliczna: AP:257.30[IU/L]\nBilirubina ca\u0142kowita TBIL: TBIL:0.60[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP: CRP:0.70[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:97[%]\nWska\u017anik PT: PT%:96[%]\nGlukoza osocze: GLU-os:*[mg/dl]\nGlukoza osocze: GLU-os:*[mg/dl]\nGlukoza osocze: GLU-os:*[mg/dl]\nBia\u0142ko ca\u0142kowite: TP:5.80[g/dl]\nBia\u0142ko ca\u0142kowite: TP:6.30[g/dl]\nKreatynina: CREA:0.40[mg/dl]\nKreatynina: CREA:0.40[mg/dl]\nKreatynina: CREA:0.40[mg/dl]\nMocznik: UREA:17.00[mg/dl]\nMocznik: UREA:21.00[mg/dl]\nMocznik: UREA:14.00[mg/dl]\nASPAT: AST:51.00[IU/L]\nASPAT: AST:62.00[IU/L]\nASPAT: AST:55.00[IU/L]\nALAT: ALT:47.00[IU/L]\nALAT: ALT:50.00[IU/L]\nALAT: ALT:50.00[IU/L]\nVCA IgG\n    VCA IgG:\n    10.0[U/ml]\nRotawirusy: ROTA-KA\u0141:ujemny\nEBV IgM\n    EBV IgM:\n    10.0[U/ml]\nEBNA IgG\n    EBNA IgG:\n    3.0[U/ml]\nCytomegalia   IgA\n    CMVA:Ujemny \n    0,9\nCytomegalia   IgM: CMVM:Ujemny(0.00)\nCytomegalia   IgG: CMVG:Graniczny(5)[AU/ml]\nToksoplazmoza   IgA: TXA:*\nToksoplazmoza  IgM: TXM:Ujemny(0.03)\nToksoplazmoza IgG: TXG:Ujemny(0)[IU/ml]\nNT- proBNP: NTpBNP:7447.00[pg/ml]\nTSH: TSH:4.54[uIU/ml]\nGlukoza w surowicy: GLU-sur:77[mg/dl]\nGlukoza w surowicy: GLU-sur:80[mg/dl]\nGlukoza w surowicy: GLU-sur:80[mg/dl]\nGlukoza w surowicy: GLU-sur:72[mg/dl]\nWzrost pacjenta: WzrostPac:57[cm]\nWzrost pacjenta: WzrostPac:56[cm]\nWzrost pacjenta: WzrostPac:57[cm]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:58.9[ml/min/1,73m2]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:57.8[ml/min/1,73m2]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:58.9[ml/min/1,73m2]\nFT3 III: FT3 III:4.82[pg/ml]\nFT4II: FT4II:1.69[ng/dl]\nNorowirusy w kale\n    Norowir-G1:nie wykryto\n    Norowir-G2:nie wykryto\nNorowirusy w kale\n    Norowir-G1:nie wykryto\n    Norowir-G2:wykryto\nNorowirusy w kale\n    Norowir-G1:wykryto\n    Norowir-G2:wykryto\n    COMMENT_HL7:\nNorowirusy w kale\n    Norowir-G1:nie wykryto\n    Norowir-G2:wykryto\nNorowirusy w kale\n    Norowir-G1:nie wykryto\n    Norowir-G2:nie wykryto\nROTA/ADENO-ka\u0142\n    ROTA-KA\u0141:ujemny\n    ADENO-KA\u0141:ujemny\nROTA/ADENO-ka\u0142\n    ROTA-KA\u0141:ujemny\n    ADENO-KA\u0141:ujemny\nBadanie osadu z moczu odwirowanego\n    werytrocyt:1/cz. wy\u0142.[ul]\n    wkrwbia\u0142e:1[ul]\n    wnab\u0142onekp:pojedyncze w pw\n    wbakter:poj. w pw\n    w\u015bluz:poj. pasma\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    BTA-IGG:ujemny\n    UWAGI:\n    NR-KS:K18/000495\n    DONACJA:Z511418000233\n    DONACJA:Z510718000551\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    UWAGI:\n    NR-KS:K18/000622\n    DONACJA:Z510618000415\n    DONACJA:Z510118000437\nGrupa krwi noworodkowa (do 4. m-ca \u017cycia)\n    BTA-IGG:- (ujemny)\n    NR-KS:G18/002683\n------------------------------------------------\nICD10\n------------------------------------------------\nQ90.9\nQ21.2\nI50.0\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.00\n88.718\n87.440\n88.761\n------------------------------------------------"
}